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SUMMARY.-A controlled study has been made of the constitutional back-
ground of 300 cases of endometrial adenocarcinoma. The control group was
age matched and drawn from the same patient population pool as were the
adenocarcinoma cases.
Endometrial adenocarcinoma was shown to be associated unduly frequently
with hypertension, nulliparity and the late age of menopause. No association
was found between endometrial adenocarcinoma and obesity, diabetes mellitus,
thyroid disease or extragenital malignant disease.
It is suggested that these results are explicable on the basis that adrenal
dysfunction may be an aetiological factor in the development of endometrial
adenocarcinoma.
IT is widely believed that patients suffering from endometrial carcinoma show
an unduly high incidence ofassociated obesity, hypertension and diabetes mellitus,
that they are frequently unmarried, commonly nulliparous and often have an
unusually late menopause; this belief has led to the suggestion that adenocarci-
noma of the endometrium develops against a background of endocrine abnor-
mality, particular emphasis having been placed on the possibility oflong standing
pituitary dysfunction being an aetiological factor (Way, 1954). Some of the
data on which this view is based is assembled in Tables I and II and it is apparent
that there is a quite considerable lack of agreement. It must also be pointed
out that many of these studies have not utilised a control group to determine
whether or not the incidence of any given abnormality is unusually and specifi-
cally excessive; further, in those relatively few reports where control figures have
been given, these have often been based on nationally derived data which have
not necessarily been applicable to the particular population from which the
cases of endometrial adenocarcinoma had been drawn.
In the present study the constitutional background of 300 consecutive cases
of endometrial adenocarcinoma has been compared to that of an age matched
control group drawn from the same patient population pool. These groups have
also been used to study the suggestion that endometrial adenocarcinoma may be
associated unduly frequently with thyroid disease (Davis, 1964; Wynder, Escher
and Mantel, 1966) and with concomitant extragenital malignant neoplasms
(Yahia, Benirschke and Sturgis, 1963; Lynch, Krush, Larsen and Magnuson,
1966).
MATERIAL
The records were studied of 300 consecutive cases of histologically proven
adenocarcinoma of the endometrium seen in the gynaecological division of theCONSTITUTIONAL STIGMATA OF ENDOMETRIAL CARCINOMA
TABLE L.-Reported Incidence of Constitutional Factors in Endometrial
Adenocarcinoma
Percentage Incidence
t, A
Author
Smith
Moss
Palmer, Rheinhard, Sadugor and
Goltz
Bastiaanse .
Waterman, Raphael and
Moskowsky
Way
Kimbell
Peel
Sommers and Meissner.
Kottmeier
Pentecost and Brack
Damon
Roberts
Dibbelt, Muller and Ehlers
Thiede and Lund
Twombly and Jacobovitz
Miller, Robertson, Swanson and
Walker
Yahia, Benirschke and Sturgis
Boutselis, Bair, Vorys and Ullery
Javert and Renning
Graham
Davis
Hoynck van Papendrecht
Garnet
Lynch, Krush, Larsen and
Magnuson
Wynder, Escher and Mantel
Dunn, Merchant, Bradbury and
Stone
No. of Hyper- Nulli-
Year patients Obesity tension parity Diabetes
1941 . 307 . 28 56 41 4
1947 23 . 70 78 43 34
1949 957 . 75 78 19 17
1952 264 . 21 64 17-4 7-2
1952
1954
1954
1956
1957
1959
1959
1960
1961
1962
1962
1962
1962
1963
1963
1963
1964
1964
1965
1966
184
153
245
107
38
617
115
438
223
161
339
82
200
153
269
610
81
525
115
103
50
64
31
63
36
50
26
53
12
40
64
22- 1
70
17-3
28
48
37 23
- 26
46
53 38
- 32-5
- 39-6
40
57-7
42 26
- 29
16.5
45
52
40
77
35 6
35
46
21
45
30
22
41 -3
40
42
8-1
29
1 -6
4-7
30
7
8-7
19
1 3
6-5
9
14-6
4
14
17
3-6
14
5-3
12
57
. 1966 . 154 . 80 65 - 42
1966 . 112 . 30 33 29 4
1968 . 55 . 72-2 51-9 28-7 47-3
TABLE II.-Reported Mean Age of Menopause in Patients with Endometrial
Adenocarcinoma
Author
Palmer, Reinhard, Sadugor and Goltz (1949)
Waterman, Raphael and Moskowsky (1952)
Winder, Escher and Mantel (1966)
Dibbelt, Muller and Ehlers (1962)
Way (1954)
Kottmeier (1959)
Boutselis, Bair, Vorys and Ullery (1963)
Scheffey, Thudium and Farrell (1943)
Kimbell (1954) .
Twombly and Jacobowitz (1962)
Number
957
184
112
161
153
617
269
127
173
82
Mean age of
menopause
(in years)
49 -05
49-6
49 -53
49-7
51-5
51 6
49
49
49-5
48-4
United Manchester Hospitals (St. Mary's Hospitals). A control group of 300
women suffering from non-malignant disease was drawn from the general surgical
and medical wards of the United Manchester Hospitals (Manchester Royal
Infirmary); this control group was age matched in 5 year groups with the adeno-
carcinoma series. In selecting the control group any patient suffering from a
condition known to be specifically associated with obesity, hypertension, diabetes
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mellitus or endocrine disorder was excluded. The composition of the control
group is shown in Table 111.
TABLE III. CoMposition of Control Series
Number of
Disease cases
Appeindicitis 75
Chronic peptic ulcer 59
Chronic rheumatic heart disease . 56
Diverticulitis . . 28
Hernia . . . . 18
Chronic bronchitis . . 18
Ulcerative colitis . 12
Haemolytic anaemia .
Sarcoidosis . . 3
Asthma . . 2
Idiopathic steatorrhoea . . . 10
Miscellaneous . . . . 6
Crohn's disease . . . . . 8
For the purposes ofthis study hypertension was defined as a persistent diastolic
pressure of 100 mm. of mercury or above; a patient was considered to have severe
hypertension if her diastolic pressure was persistently 110 mm. of mercury or
above.
Very few of the patients had been weighed and it was therefore difficult to
obtain objective criteria of obesity. In all cases, however, the records contained
a comment as to whether the patient was " thin ", " of average weight ", " obese "
or "' grossly obese " and patients falling into the latter two classifications were
considered as obese in this study. It was thought that this classification was,
despite its obvious limitations, reasonably valid and that any faults introduced by
its use would be equally applicable to both the groups studied.
In hardly any of the cases, in either group, had glucose tolerance tests been
performed, though all patients had had their urine tested for glycosuria. A patient
was therefore classed as diabetic if either she was known to be suffering from
established diabetes mellitus before the onset of her current illness and was
receiving treatment for this condition or if urine testing during her current illness
showed glycosuria that was proven by blood studies to be due to diabetes mellitus.
RESULTS
The age distribution ofpatients with endometrical adenocarcinoma is shown in
Table IV and is similar to that found in other series.
TABLE IV. Age Distribution of Cases of Endometrial Adenocarcinoma
<40 41-45 46-50 51-55 56-60 61-65 66-70 71-75 > 75
5 12 31 68 67 47 35 25 10
Age of menopause. The mean age at which a natural menopause occurred in
the adenocarcinoma group was 49 1 years (standard deviation ± + 4-7 years).
The mean age of natural menopause in the control series was 47-9 years (standard
deviation = 4-36 years). The standard error of the difference of the means is
0*55 and the observed difference of 1f2 years is therefore probably significant.
It has been suggested that it is probably more pertinent to consider theCONSTITUTIONAL STIGMATA OF ENDOMETRIAL CARCINOMA
incidence of patients in each group whose menopause occurred after the age of 52
(Peel, 1956). In the adenocarcinoma series 53 patients had not reached their
menopause by the age of 53, whilst in the control group 33 women were still
premenopausal at this age. This difference is probably significant (chi square
= 4-9 P = less than 0 05).
Marital state. In the adenocarcinoma series 58 patients (19-33%) were
unmarried whilst in the control series 35 women (11.66%) were single. This
difference is probably significant (chi square = 6-2 P = less than 0.05).
Parity. Amongst the patients with endometrial adenocarcinoma 112 (37.30%)
were nulliparous as were 71 women (23.7%) in the control series. This is a
significant difference (chi square = 12-58 P = less than 0-001). If the incidence
of nulliparity is considered only in those women who were married then the
figures for the adenocarcinoma and the control series respectively were 54 of 242
patients (22.3%) and 36 of 265 patients (13.6%). This difference is still probably
significant (chi square = 6 017 P = less than 0.05).
Hypertension. One hundred and six (35.330%) ofthe patients with endometrial
adenocarcinoma were hypersensitive as were 75 (25%) ofthe women in the control
series. This difference in incidence is a significant one (chi square = 7 1 P = 0.01).
Within these groups were 47 (15.66%) cases of severe hypertension in the adeno-
carcinoma series and 29 (9.66%) severely hypertensive women in the control
series. This difference is also probably significant (chi square = 4-35 P = less
than 0.05).
Obesity. In the adenocarcinoma group 102 patients (3400) were classed as
obese as compared to 94 patients (31.33%) in the control series. This difference
in incidence is clearly not significant.
Diabetes mellitus. Thcre were 11 diabetics (3.660%) amongst the patients with
adenocarcinoma as compared to 9 diabetics (300) in the control series; this is not
a significant difference.
Thyroid disease. A history of past or present thyroid disease was noted in
13 (4.330o) of the patients with endometrical adenocarcinoma and in 18 (6%) of
the women in the control group.
Concomitant malignant disease. Six of the patients with endometrial adeno-
carcinoma had a concomitant extragenital malignant tumour as did also 6 patients
in the control series.
DISCUSSION
In a study of this type it is necessary to consider the validity of the control
group. The one that we have used was drawn from the same patient population
as were the cases of endometrial adenocarcinoma: this is a necessary precaution
in so far as it is probable that both the incidence of obesity and the average age
of menopause are subject to a quite considerable regional and socio-economic
variation. Although every effort was made to exclude from the control group
any patient suffering from a disease known to be associated with hypertension,
diabetes or endocrine disorder it is almost impossible to exclude totally conditions
uninfluenced by obesity; thus it is probable that cases of diverticulitis, hernia and
chronic bronchitis may be exacerbated by obesity and therefore more likely to be
admitted to hospital. However, the reverse also applies and patients with
ulcerative colitis, Crohn's disease or steatorrhoea are unlikely to be overweight;
this second group probably neutralises the tendency to overestimate the incidence
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of obesity that it is virtually inherent in any control series that is drawn from a
hospital population. It may be argued that it would be better to use a control
series of well women; quite apart from the problems entailed in obtaining data
from an age matched group of such women, it is extremely difficult to reduplicate
the socio-economic stratification that is characteristic of any particular hospital.
Ifthe validity of the control group is accepted then it is clear that endometrial
adenocarcinoma is not, in the population studied, specifically associated
with
obesity. It may be thought that the incidence of obesity in the adenocarcinoma
group had been underestimated in so far as patients with a malignant tumour often
lose weight before their illness is diagnosed. All patients in this group had,
however, been questioned as to weight loss and the number who had lost any
appreciable amount ofweight was too small to be of any real significance.
It is also apparent that there is, in ourpatient population, no excess of diabetics
amongst patients with endometrial adenocarcinoma. The incidence of such
patients in our series of 3.6% is similar to that found by Peel (1956), Miller et al.
(1962), Javert and Renning (1963) and Wynder, Escher and Mantel (1966), but
is totally at variance with those of other workers in whose series between 25%
and 50% of patients with endometrial adenocarcinoma were classed as diabetic.
It isquite clearthat twototally differentparameters are being cited in these various
studies, one being the incidence of true diabetics and the other the incidence
of
disturbance in carbohydrate metabolism; this being so any attempt to compare
results is a pointless exercise. There is, however, no convincing evidence that
frank diabetes mellitus occurs unduly commonly in patients with endometrial
adenocarcinoma anditmaybearguedthatthisis a morerelevant findingthan is
theincidenceofabnormalglucosetolerancetestsinthiscondition. Firstly, very
few studies have beenmade oftheincidence ofabnormal glucose tolerance tests
inhealthy women ofthe age groupinwhichendometrial adenocarcinoma occurs;
certainly, studies ofglucose metabolism have not been made in age matched
controlgroups fromthe samepopulationpoolin anyreported series thus making
it difficult to assess the significance or otherwise of any data obtained from the
adenocarcinomapatients. Secondly,thosestudiesinwhichtherehasbeen ahigh
incidence ofabnormalglucosetolerancetestsinpatients withendometrial adeno-
carcinoma have often been those in which these patients were also reported as
having anunusuallyhighincidenceofobesity; astherelationshipbetweenobesity
and disturbances inglucose metabolism is wellknownthis factor may have con-
siderably biased their results. Thirdly, it is possible, indeed probable, that
malignant tumours of any type may have a non-specific effect on the glucose
tolerance test (Vander, 1959). Lastly, there isthe important consideration that
exogenousoestrogens canimpairglucosetolerance (Goldman and Ovadia, 1969):
as there is considerable evidence to suggest that hyperoestrogenism may, in a
proportion of cases, be an aetiological factor in endometrial adenocarcinoma
(Andrews, 1961)itcouldbeexpectedthatsuchpatientscouldalsohave abnormal
glucose tolerance tests because oftheir excess endogenous oestrogen. All these
factorscomplicate thestudyofglucosetolerance testsinendometrialadenocarci-
noma and dilute the significance of any results obtained thus making it more
profitable to study simply the incidence of diabetes mellitus.
Our study does confirm the association between endometrialadenocarcinoma
andhypertension, thisassociationholdingforbothmildand severe hypertension.
It canbearguedthatthe excessofhypertensionoftennotedinpatients with this
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tumourreflects the high incidence ofassociated obesity and is due to the misleading
readings obtained by taking blood pressure measurements from a very plump arm.
This does not, however, hold true for our series in which there was no excess of
obese patients to the adenocarcinoma group.
Our results also confirm that patients with endometrial adenocarcinoma show a
significant tendency to be nulliparous, to be unmarried and to have a late meno-
pause; we have not been able to confirm any association with thyroid disease or
with extragenital malignant neoplasm.
These findings require an interpretation and it could be suggested that they
are, when taken together, explicable on the basis of an abnormality in adrenal
function, this being responsible both for a disturbance in oestrogen metabolism
and for the presence of hypertension. It is well established that tumours and
marked hyperplasia of the adrenal glands can cause such abnormalities, e.g. in
Cushing's syndrome, but it is as yet far from clear whether or not relatively minor
adrenal lesions, such as mild cortical hyperplasia or small cortical adenomata, can
also produce this complex. It has indeed been claimed that many cases of essen-
tial hypertension are due to relatively minor abnormalities of the adrenals (Conn,
1964) but the truth or otherwise of this contention is not yet fully established.
The hypothesis of adrenal overactivity is an attractive one for it would explain
not only the constitutional background of patients with endometrial adeno-
carcinoma but can also be incriminated as an aetiological factor inthe development
of this neoplasm, for which a basis of hyperoestogenism is, in a proportion of
cases, well established (Andrews, 1961). This hypothesis is sufficiently feasible
for us to suggest that a much more detailed study of adrenal function and struc-
ture in cases of endometrial adenocarcinoma would be a worthwhile undertaking.
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